Sierra oncology stock forecast

Why Sierra Oncology, Inc. (SRRA) Is Down A Whooping -3.73% ... Jan 16, 2020 · Sierra Oncology, Inc. (NASDAQ:SRRA) is among the top losers of the stock market today, sinking -3.73% or (-0.02 points) to $0.42 from its previous close of $0.44. Does this decline mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 272402 contracts so far this session. SRRA Sierra Oncology Inc — Stock Price and ... - StockTwits

Based on 1 analyst offering 12 month price targets for Sierra Oncology in the last 3 months. The average price target is $48.00 with a high forecast of $48.00 and  Sierra Oncology, Inc. SRRA. Real-time BATS EXCHANGE - 03/24 04:00:05 pm. Get today's Sierra Oncology Inc stock price and latest SRRA news as well as Sierra Oncology real-time stock quotes, technical analysis, full financials and more. Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted  How has Sierra Oncology's share price performed over time and what events caused price Are Insiders Buying Sierra Oncology, Inc. (NASDAQ:SRRA) Stock ? Stockopedia rates Sierra Oncology Inc as a Adventurous Sucker Stock . 2 brokers rate it as a 'Strong Buy'. Click to view NMQ:SRRA's StockReport.

Sierra Oncology: Significant Potential Upside In 2018 ...

Sierra Oncology (NasdaqGM:SRRA) - Share price, News ... Are Insiders Buying Sierra Oncology, Inc. (NASDAQ:SRRA) Stock? 4 months ago | Simply Wall St. Sierra Oncology, Inc. (NASDAQ:SRRA): What Does Its Beta Value Mean For Your Portfolio? How is Sierra Oncology forecast to perform in the next 1 to 3 years based on estimates from 2 analysts? 21.7%. SRRA | Sierra Oncology Inc. Stock Price & News - WSJ View the latest Sierra Oncology Inc. (SRRA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

SRRA Sierra Oncology, Inc. Common Stock - NASDAQ.com

SRRA Stock Price, Forecast & News (Sierra Oncology) Exploring Sierra Oncology (NASDAQ:SRRA) stock? View SRRA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

Sierra Oncology, Inc Stock Forecast, "SRRA" Stock ...

Get today's Sierra Oncology Inc stock price and latest SRRA news as well as Sierra Oncology real-time stock quotes, technical analysis, full financials and more. Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted  How has Sierra Oncology's share price performed over time and what events caused price Are Insiders Buying Sierra Oncology, Inc. (NASDAQ:SRRA) Stock ?

Stock Comparison: Compare Sierra Oncology, Inc. (SRRA) to ...

How has Sierra Oncology's share price performed over time and what events caused price Are Insiders Buying Sierra Oncology, Inc. (NASDAQ:SRRA) Stock ? Stockopedia rates Sierra Oncology Inc as a Adventurous Sucker Stock . 2 brokers rate it as a 'Strong Buy'. Click to view NMQ:SRRA's StockReport. View live SIERRA ONCOLOGY INC chart to track its stock's price action. Find market predictions, SRRA financials and market news. Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Last Price. -$0.22 (-2.29%). Change. 23.0K. Volume. $97.5M. Market Cap. NASDAQ: SRRA. Created with Highstock 1.3.5 Feb 26 Mar 4 Mar 11 Mar 18 Mar 25 $8 $10 $12 $14 $16. Loading 1dy. 1mo. 6mo. 1yr. 5yr. $9.38. Last Price. SRRA Sierra Oncology, Inc. daily Stock Chart Book/sh, 14.25, P/B, 0.63, EPS next Y, -15.70%, ROA, -87.40%, Target Price, 5.67, Perf Year, -85.56%. Cash/sh   Learn about SRRA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a Stock Style. Large-Cap 

Sierra Oncology Inc is a clinical-stage drug development company. $10.49 SHARE PRICE (As of Thursday Closing) Sierra Oncology Stock Performance  22 Jan 2020 Sierra Oncology, Inc. (SRRA) will effect a one-for-forty (1-40) reverse split of its Common Stock. The reverse stock split will become effective on  Sierra Oncology Share Price and News. We are a clinical stage drug development company advancing next generation DNA Damage Response ( DDR)  Sierra Oncology Announces Reverse Stock Split · By PR Newswire. Jan 22, 2020 7:00 AM EST. 3 Cutting-Edge Biotech Stocks That Can Double in Value. Real time Sierra Wireless (SWIR) stock price quote, stock graph, news & analysis . SRRA Stock Price, Forecast & News (Sierra Oncology) Exploring Sierra Oncology (NASDAQ:SRRA) stock? View SRRA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.